Clincosm LogoSign in Get a demo

bioequivalence

Showing 1 - 25 of 151
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 100/1000 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 100/1000 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza Garcia (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza Garcia, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Diabetes, Type 2 Trial in San Pedro Garza García (Sitagliptin/Metformin HCl 50/500 mg extended release

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/500 mg extended release film-coated tablet
  • San Pedro Garza García, Nuevo León, Mexico
    Avant Santé Research Center S.A. de C.V.
Nov 8, 2023

Bioequivalence, Schizophrenia Trial in Qingdao (Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and

Recruiting
  • Bioequivalence
  • Schizophrenia
  • Drug: Test (T) Amisulpride orally disintegrating tablets (200mg). Produced and supplied by Zezheng (Shanghai) Biotechnology Co., Ltd.
  • Qingdao, Shandong, China
    The Affiliated Hospital of Qingdao University Phase I Clinical R
Sep 27, 2023

Bioequivalence, Therapeutic Equivalency Trial in Moscow (Humulin® Regular, Rinsulin® R)

Completed
  • Bioequivalence
  • Therapeutic Equivalency
  • Humulin® Regular
  • Rinsulin® R
  • Moscow, Russian Federation
    "National Medical Research Center of Endocrinology" of the Minis
Sep 15, 2023

Bioequivalence Trial in Larissa (Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,

Recruiting
  • Bioequivalence
  • Fluticasone propionate 500 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
  • ADVAIR DISKUS® 500/50
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Aug 29, 2023

Bioequivalence Trial in Larissa (Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals,

Recruiting
  • Bioequivalence
  • Fluticasone propionate 250 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
  • ADVAIR DISKUS® 250/50
  • Larissa, Thessaly, Greece
    BECRO Clinical Facility
Aug 1, 2023

Bioequivalence Trial in Moscow (Perindopril/Indapamide/Amlodipine 8 mg/2.5 mg/10 mg tablet / Triplixam® 10 mg/2.5 mg/10 mg

Recruiting
  • Bioequivalence
  • Perindopril/Indapamide/Amlodipine 8 mg/2.5 mg/10 mg tablet / Triplixam® 10 mg/2.5 mg/10 mg tablet
  • Moscow, Russian Federation
    Ligand Research LLC
Jul 7, 2023

Bioequivalence Trial in Yaroslavl (Clopidogrel film-coated tablet 75 mg, Plavix® film-coated tablet 75 mg)

Recruiting
  • Bioequivalence
  • Clopidogrel film-coated tablet 75 mg
  • Plavix® film-coated tablet 75 mg
  • Yaroslavl, Yaroslavl Region, Russian Federation
    State Autonomous Healthcare Facility of the Yaroslavl Region "Cl
Jun 28, 2023

Bioequivalence Trial in Haikou (Amphotericin B liposome for injection, AmBisome)

Active, not recruiting
  • Bioequivalence
  • Amphotericin B liposome for injection
  • AmBisome
  • Haikou, Hainan, China
    Haikou people's Hospital
Jun 12, 2023

Bioequivalence Trial in Erfurt (Rivastigmine twice-weekly 9,5 mg/24 h, Exelon® 9.5 mg/24 h)

Active, not recruiting
  • Bioequivalence
  • Rivastigmine twice-weekly 9,5 mg/24 h
  • Exelon® 9.5 mg/24 h
  • Erfurt, Thuringia, Germany
    SocraTec R&D GmbH, Clinical Pharmacology Unit
May 22, 2023

Bioequivalence Trial in Erfurt (RID-TDS 13.3 mg/24 h, Exelon® 13.3 mg/24 h)

Recruiting
  • Bioequivalence
  • RID-TDS 13.3 mg/24 h
  • Exelon® 13.3 mg/24 h
  • Erfurt, Thüringen, Germany
    SocraTec R&D GmbH, Clinical Pharmacology Unit
May 2, 2023

Bioequivalence Trial in Tempe, Lincoln (efgartigimod PH20 SC as a prefilled syringe presentation, efgartigimod PH20 SC as a vial

Recruiting
  • Bioequivalence
  • efgartigimod PH20 SC as a prefilled syringe presentation
  • efgartigimod PH20 SC as a vial + syringe presentation
  • Tempe, Arizona
  • +1 more
Apr 5, 2023

Bioequivalence Trial in Edison (Oseltamivir Phosphate 75 mg capsules, Tamiflu capsules 75 mg)

Completed
  • Bioequivalence
  • Oseltamivir Phosphate 75 mg capsules
  • Tamiflu capsules 75 mg
  • Edison, New Jersey
    Austarpharma Llc
Feb 1, 2023

Bioequivalence Trial (Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals, ADVAIR DISKUS

Not yet recruiting
  • Bioequivalence
  • Fluticasone propionate 1000 mcg and salmeterol xinafoate 50 mcg/Respirent Pharmaceuticals
  • ADVAIR DISKUS 100/50
  • (no location specified)
Jan 20, 2023

Bioequivalence Trial in Moscow (Ramipril/Hydrochlorothiazide tablet 10 mg/25 mg, Tritace® Plus tablet 10 mg/25 mg)

Not yet recruiting
  • Bioequivalence
  • Ramipril/Hydrochlorothiazide tablet 10 mg/25 mg
  • Tritace® Plus tablet 10 mg/25 mg
  • Moscow, Russian Federation
    Separate medical division "Comed" (Ligand Research LLC)
Jan 5, 2023

Bioequivalence, Healthy Subjects Trial in Amman (Darfen 400, 400 mg ibuprofen coated tablets (512 mg ibuprofen sodium

Completed
  • Bioequivalence
  • Healthy Subjects
  • Darfen 400, 400 mg ibuprofen coated tablets (512 mg ibuprofen sodium dihydrate)
  • Nurofen® Forte Express, 400 mg ibuprofen coated tablets (512 mg ibuprofen sodium dihydrate)
  • Amman, Jordan
    ACDIMA Center for Bioequivalence and Pharmaceutical Studies
Dec 15, 2022

Bioequivalence, Healthy Subjects Trial in Amman (Efez 50 mg eplerenone film-coated tablets, INSPRA® 50 mg eplerenone film-coated

Completed
  • Bioequivalence
  • Healthy Subjects
  • Efez 50 mg eplerenone film-coated tablets
  • INSPRA® 50 mg eplerenone film-coated tablets
  • Amman, Jordan
    ACDIMA Center for Bioequivalence and Pharmaceutical Studies
Dec 15, 2022

Pharmacodynamics, Pharmacokinetics, Bioequivalence Trial in Yaroslavl (GP40141, Nplate)

Recruiting
  • Pharmacodynamics
  • +2 more
  • Yaroslavl, Russian Federation
    Yaroslavl Region "Clinical Hospital No. 3", ,, Mayakovskogo st.,
Dec 14, 2022

Bioequivalence Trial in Yaroslavl (Atorvastatin film-coated tablet 40 mg / Liprimar® film-coated tablet 40 mg)

Recruiting
  • Bioequivalence
  • Atorvastatin film-coated tablet 40 mg / Liprimar® film-coated tablet 40 mg
  • Yaroslavl, Russian Federation
    State Budgetary Healthcare Institution of the Yaroslavl Region "
Nov 30, 2022

Pharmacokinetics, Bioequivalence Trial in Dallas (Sumatriptan (via Intraject System))

Completed
  • Pharmacokinetics
  • Bioequivalence
  • Sumatriptan (via Intraject System)
  • Dallas, Texas
    Covance, Inc
Nov 8, 2022

Bioequivalence, Diabetes, Type 2 Trial in Mount Royal (Sitagliptin/Metformin HCl 50/850 mg film-coated tablet)

Completed
  • Bioequivalence
  • Diabetes Mellitus, Type 2
  • Sitagliptin/Metformin HCl 50/850 mg film-coated tablet
  • Mount Royal, Quebec, Canada
    Algorithme Pharma
Sep 20, 2022

Bioequivalence, Type 2 Diabetes Trial in Mount Royal (Sitagliptin/metformin HCl (HCl) 50/1000 mg film-coated tablet)

Completed
  • Bioequivalence
  • Type 2 Diabetes
  • Sitagliptin/metformin hydrochloride (HCl) 50/1000 mg film-coated tablet
  • Mount Royal, Quebec, Canada
    Algorithme Pharma
Sep 20, 2022

Bioequivalence Trial in Karachi (Lamotrigine tablet)

Completed
  • Bioequivalence
  • Lamotrigine tablet
  • Karachi, Sindh, Pakistan
    Center for Bioequivalence Studies and clinical research
Sep 5, 2022